Back to News
Sep 16, 2025 12:30 PM

Eli Lilly To Invest $5 Billion In New Virginia Manufacturing Facility To Support Cancer Drugs Manufacturing

Eli Lilly and Co. (NYSE:LLY) announced on Tuesday that it plans to build a $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County.

The new facility will be Eli Lilly’s first fully integrated site dedicated to both active pharmaceutical ingredient (API) production and drug products, supporting its growing bioconjugate platform and monoclonal antibody portfolio.

LLY is gathering positive momentum. Check the full analysis here.

Earlier this year, Eli Lilly revealed plans to strengthen U.S. drug production across multiple therapeutic areas by constructing four new manufacturing sites nationwide.

The Virginia plant is the first of these new sites to be officially announced and is part of Eli Lilly's broader $50 billion investment in U.S. facilities since 2020.

The facility will also enhance domestic production of antibody-drug conjugates ...